| Financial Year |
March 31 2023 |
| Monetary Funds |
526,190,074.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,505,007,390.25 |
| Advances to Suppliers |
52,281,214.43 |
| Other Receivables |
8,410,660.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,622,552,938.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,018,438.62 |
| Total Current Assets |
3,774,540,292.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
504,939,313.03 |
| Under-construction Projects |
58,437,320.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
294,106,585.23 |
| R&D expenses |
287,241,524.08 |
| Goodwill |
98,968,519.23 |
| Long-Term Deferred and Prepaid Expenses |
21,568,095.44 |
| Deferred Income Tax Assets |
25,741,473.04 |
| Other Non-Current Assets |
754,147.17 |
| Sub-Total of Non-Current Assets |
1,362,045,580.46 |
| Total Assets |
5,136,585,872.75 |
| Short-Term Loans |
967,983,101.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
237,475,197.53 |
| Accounts Payable |
1,294,606,562.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
52,829,569.48 |
| Taxes Payable |
28,778,138.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
164,850,625.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
200,175,635.14 |
| Other Current Liabilities |
67,386.71 |
| Sub-Total of Current Liabilities |
2,975,511,867.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
62,383,988.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,672,425.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
148,038,013.34 |
| Total Liabilities |
3,123,549,880.60 |
| Paid-In Capital(Or Share Stock) |
261,961,441.00 |
| Capital Surplus |
1,341,543,119.36 |
| Surplus Reserve |
63,058,880.17 |
| LESS:Treasury Stock |
58,999,635.79 |
| Undistributed Profits |
413,752,294.69 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,013,035,992.15 |
| Owner's Equity（Stockholder's Equity） |
2,013,035,992.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,136,585,872.75 |
